Cite

HARVARD Citation

    Enver, M. et al. (n.d.). Comparing outcomes of patients with epidermal growth factor receptor (EGFR) therapy resistant mutations (EXON 20 and T790M). Lung cancer. pp. S39-. [Online]. 
  
Back to record